ALISO VIEJO, Calif.--(BUSINESS WIRE)--Clarient, Inc. (Nasdaq:CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry, today announced it has completed a financing arrangement with Gemino Healthcare Finance. This new agreement consists of a senior secured revolving credit facility pursuant to which Clarient may borrow up to $8 million, subject to adjustment based on the amount of Clarient’s qualified accounts receivable and certain liquidity factors.
